Category: Press Release

Periocream: The Future Commercial Winner for bonyf
Post

Periocream: The Future Commercial Winner for bonyf

Knokke-Heist (Belgium), 11 August 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) is preparing to launch Periocream, a groundbreaking dental treatment designed exclusively for dental professionals. At bonyf, we expect our Notified Body to release the final report shortly, confirming the product’s readiness for market.

Annual Results 2024
Post

Annual Results 2024

Knokke-Heist (Belgium), 30 June 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents its 2024 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.

bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy
Post

bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy

Knokke-Heist (Belgium), 15 May 2025, 6:00 p.m.; bonyf NV (Ticker: MLBON) is pleased to announce the successful launch of its first exports to the United States through a new partnership with Honest Pharma, a U.S.-based healthcare company backed by Investment 360, an investor group with a strong track record of success across a range of global industries.

bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne
Post

bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne

Knokke-Heist (Belgium), 13 March 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents PerioTabs® and Periocream at the future exhibition in Cologne from 25-29 March 2025 at the IDS, leading global trade fair for the dental community. PerioTabs®-Periocream’s participation in this premier event highlights its potential to revolutionize dental care practices globally. Visit bonyf at the IDS Hall 5.2, Booth 131.

bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy
Post

bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy

Knokke-Heist (Belgium), 18 February 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) today announced its strategic plan to pursue a dual listing on the Nasdaq Stock Market while maintaining its current listing on Euronext Paris. This initiative is aimed at expanding the company’s global footprint, diversifying its investor base, and accelerating growth opportunities in the U.S. and international markets.

bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market
Post

bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market

Knokke-Heist (Belgium), 10 December 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is committed to advancing oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union’s Medical Device Regulation (MDR), marking a new chapter in its pursuit of excellence.

  • 1
  • 2
  • 4